Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens

  • Elke Bleifuss
  • , Henriette Bendz
  • , Birgit Sirch
  • , Sylvia Thompson
  • , Anna Brandl
  • , Valeria Milani
  • , Michael W. Graner
  • , Ingo Drexler
  • , Maria Kuppner
  • , Emmanuel Katsanis
  • , Elfriede Noessner
  • , Rolf Dieter Issels

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

The goal of immune-based tumor therapies is the activation of immune cells reactive against a broad spectrum of tumor-expressed antigens. Vaccines based on chaperone proteins appear promising as these proteins naturally exist as complexes with various protein fragments including those derived from tumor-associated antigens. Multi-chaperone systems are expected to have highest polyvalency as different chaperones can carry distinct sets of antigenic fragments. A free-solution isoelectric focusing (FS-IEF) technique was established to generate chaperone-rich cell lysates (CRCL). Results from murine systems support the contention that CRCL induce superior anti-tumor responses than single chaperone vaccines. We established an in vitro model for human melanoma to evaluate the capacity of CRCL to transfer endogenously expressed tumor antigens to the cross-presentation pathway of dendritic cells (DC) for antigen-specific T cell stimulation. CRCL prepared from human melanoma lines contained the four major chaperone proteins Hsp/Hsc70, Hsp90, Grp94/gp96 and calreticulin. The chaperones within the melanoma cell-derived CRCL were functionally active in that they enhanced cross-presentation of exogenous peptides mixed into the CRCL preparation. Superior activity was observed for Hsp70-rich CRCL obtained from heat-stressed melanoma cells. Despite the presence of active chaperones, melanoma cell-derived CRCL failed to transfer endogenously expressed melanoma-associated antigens to DC for cross-presentation and cytotoxic T cell (CTL) recognition, even after increasing intracellular protein levels of tumor antigen or chaperones. These findings reveal limitations of the CRCL approach regarding cross-presentation of endogenously expressed melanoma-associated antigens. Yet, CRCL may be utilized as vehicles to enhance the delivery of exogenous antigens for DC-mediated cross-presentation and T cell stimulation.

Original languageEnglish (US)
Pages (from-to)623-637
Number of pages15
JournalInternational Journal of Hyperthermia
Volume24
Issue number8
DOIs
StatePublished - 2008

Keywords

  • Chaperone-rich cell lysate (CRCL)
  • Cross-presentation
  • Dendritic cells
  • Heat shock proteins
  • Heat shock treatment
  • Melanoma-associated antigens

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Cancer Research

Fingerprint

Dive into the research topics of 'Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens'. Together they form a unique fingerprint.

Cite this